Contact us
Home
Publications
Search
Your Account
Help
Resources
Currently 10940 items...
Last updated 04 Dec 2008
Animal / Veterinary
(22)
Biotechnology
(398)
Chemicals
(45)
Company Financials
(2337)
Company Information
(1618)
Country
(683)
Deals & Alliances
(642)
Dental
(13)
Diagnostics
(116)
Dietary
(96)
Diseases
(434)
Drug Delivery
(79)
Drug Discovery
(89)
Finance / Investment
(18)
General Industry
(122)
Generic Drugs
(348)
Healthcare
(272)
IT & eHealth
(136)
Management / Strategy
(67)
Medical Devices
(1038)
Medical Supplies
(14)
OTC drugs
(208)
Pharmacy
(68)
Prescription Drugs
(39)
Production / Manufacturing
(62)
Regulation & Policy
(98)
Research (R&D)
(1075)
Sales & Marketing
(78)
Technology
(117)
Therapeutic
(132)
Treatments
(552)
Advanced Search
Log In
View Basket
Update Your Details
Order History
How to Buy
Formats & Delivery
Account Options
Terms & Conditions
Free Newsletter & Alerts
Industry Events
News
Special Offers »
Home
|
Search
|
Results
Search Results
Refine your Search
Results for 'Prostate Cancer - A Therapeutic & Competitive Insight'
email this page
print page
Title
Publication Date
Price
Relevance
Prostate Cancer - A Therapeutic & Competitive Insight
Drug Pipeline Update 2007
May 2007
£1275
100 %
Top 7 Cancer Indications
Therapeutic & Competitive Insights
January 2007
£5905
50 %
Analytical Tool: Prostate Cancer
A Therapeutic & Competitive Insight
May 2007
£2635
49.5 %
Triple Analysis: Antibody Drug Target Atlas in Oncology and Special Focus on Breast- and Prostate Cancer
June 2007
£4400
42.5 %
Triple Analysis: Non Small Cell Lung Cancer, Protein Kinase Inhibitors & Anti-Angiogenic Agents
October 2006
£2930
37.5 %
Stakeholder Insight: Metastatic And Hormone Refractory Prostate cancer
September 2004
£8000
35 %
Triple Progress Analysis: Lymphoma Therapeutics, Protein Kinase Inhibitors & Therapeutic Antibodies
May 2006
£2930
33 %
Stakeholder Insight: Prostate Cancer Treatment in the USA
September 2004
£8000
24.85 %
The Executive Guide to Molecular Imaging
July 2007
£595
11.55 %
Stakeholder Insight: Non-Small Cell Lung Cancer
The need for greater product differentiation in an increasingly crowded market
November 2006
£8000
11.55 %
Pipeline/Commercial Insight: Molecular Targeted Cancer Therapies
More drugs on the market, more targets in the pipeline
October 2006
£8000
10.85 %
Bookmark this Category
Del.icio.us
|
StumbleUpon
|
Reddit
GIRS Publication July 2008
GIRS News Flash November 2008
back
|
top
© 2008 Piribo Limited
About us
|
Affiliates / Advertising
|
Contact us
|
Custom Research
|
Privacy & security
Deutsch
Español
Français
Italiano
عربي (Arabic)
日本語 (Japanese)
简介 (Chinese)